Luyan Pharma Co Ltd (002788) — Capital Reinvestment Ratio
Latest as of September 2025:
0.64x
Luyan Pharma Co Ltd (002788) has a Capital Reinvestment Ratio of 0.64x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥118.98 Million) in capital expenditures (CN¥76.55 Million). See 002788 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.64x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥118.98 Million
CNY
Capital Expenditures
CN¥76.55 Million
CNY
Data as of
Sep 2025
Most recent filing
Luyan Pharma Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Luyan Pharma Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Luyan Pharma Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Luyan Pharma Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see how much is Luyan Pharma Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | CN¥688.40 Million | CN¥233.74 Million | ▼ -45.7% |
| 2024 | 0.63x | CN¥577.48 Million | CN¥361.12 Million | ▲ +54.7% |
| 2023 | 0.40x | CN¥1.31 Billion | CN¥529.21 Million | ▼ -71.3% |
| 2022 | 1.41x | CN¥232.19 Million | CN¥327.58 Million | ▼ -36.1% |
| 2020 | 2.21x | CN¥77.22 Million | CN¥170.62 Million | ▲ +109.2% |
| 2018 | 1.06x | CN¥126.77 Million | CN¥133.88 Million | ▼ -99.5% |
| 2015 | 192.80x | CN¥219.31K | CN¥42.28 Million | ▲ +40183.8% |
| 2014 | 0.48x | CN¥177.89 Million | CN¥85.14 Million | ▼ -60.6% |
| 2011 | 1.22x | CN¥28.01 Million | CN¥34.05 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow